Ascending dose trials of the safety and tolerability of Toca 511, a retroviral replicating vector encoding cytosine deaminase, in patients with recurrent high-grade glioma.
Daniel Pertschuk
Employment or Leadership Position - Tocagen
Stock Ownership - Tocagen
Timothy Francis Cloughesy
Research Funding - Tocagen
Susan Marina Chang
Research Funding - Tocagen
Manish K. Aghi
Honoraria - Tocagen
Research Funding - Tocagen
Michael A. Vogelbaum
Research Funding - Tocagen
Linda M. Liau
Research Funding - Tocagen
Bob B. Shafa
Research Funding - Tocagen
William H. Yong
Research Funding - Tocagen
Clark Chen
Research Funding - Tocagen
Santosh Kesari
Research Funding - Tocagen
Carlos E. Ibanez
Employment or Leadership Position - Tocagen
Stock Ownership - Tocagen
Omar D. Perez
Employment or Leadership Position - Tocagen
Stock Ownership - Tocagen
Joan M. Robbins
Employment or Leadership Position - Tocagen
Stock Ownership - Tocagen
Douglas J. Jolly
Employment or Leadership Position - Tocagen
Stock Ownership - Tocagen
Harry E. Gruber
Employment or Leadership Position - Tocagen
Stock Ownership - Tocagen